Nucleus RadioPharma is an end-to-end CDMO supporting radiopharmaceutical development, manufacturing, and supply from clinical programs through commercial production.
We do not compete with our clients—we partner with them to ensure life-changing radiopharmaceutical therapies reach patients efficiently and cost-effectively.
Supporting Ac-225, Lu-177, Pb-212, Cu-67, I-131 and beyond.
Purpose-built to support your program at every stage—preclinical, clinical, and commercial.
White-label solutions, supply chain expertise, and regulatory compliance.
Working with Artbio and Clarity to bring new radiotherapies to market.
We focus exclusively on manufacturing and supply chain—not isotope production—so you can bring your radiopharmaceuticals to patients faster.
Our facilities are designed from the ground up to support any formula, any process, any isotope without the limitations of legacy infrastructure.
Nucleus RadioPharma thrives from a fresh start, free from legacy constraints. This, combined with an experienced team and open communication, fuels the innovative thinking needed to scale and launch groundbreaking radiopharmaceuticals.”
Nucleus RadioPharma provides integrated capabilities designed to support radiopharmaceutical programs across development, manufacturing, isotope supply, logistics, and commercialization.
Let’s discuss how we can support your program.
Schedule a Consultation